The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Systematic review of a personalized strategy in cancer clinical trials leading to FDA approval.
Denis Leonardo Fontes Jardim
No relevant relationships to disclose
Maria Clemence Schwaederle
No relevant relationships to disclose
J. Jack Lee
No relevant relationships to disclose
David S. Hong
No relevant relationships to disclose
Alexander M. Eggermont
No relevant relationships to disclose
Richard L. Schilsky
No relevant relationships to disclose
John Mendelsohn
No relevant relationships to disclose
Vladimir Lazar
No relevant relationships to disclose
Razelle Kurzrock
No relevant relationships to disclose